LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 54

Search options

  1. Article ; Online: SARS-COV-2 and infectivity: Possible increase in infectivity associated to integrin motif expression.

    Tresoldi, Ilaria / Sangiuolo, Carla F / Manzari, Vittorio / Modesti, Andrea

    Journal of medical virology

    2020  Volume 92, Issue 10, Page(s) 1741–1742

    MeSH term(s) COVID-19/virology ; Humans ; Integrins/genetics ; Pandemics ; SARS-CoV-2/genetics ; SARS-CoV-2/pathogenicity ; Spike Glycoprotein, Coronavirus/genetics
    Chemical Substances Integrins ; Spike Glycoprotein, Coronavirus
    Keywords covid19
    Language English
    Publishing date 2020-04-10
    Publishing country United States
    Document type Letter
    ZDB-ID 752392-0
    ISSN 1096-9071 ; 0146-6615
    ISSN (online) 1096-9071
    ISSN 0146-6615
    DOI 10.1002/jmv.25831
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: SARS-COV-2 and infectivity: Possible increase in infectivity associated to integrin motif expression

    Tresoldi, Ilaria / Sangiuolo, Carla F / Manzari, Vittorio / Modesti, Andrea

    J. med. virol

    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #87350
    Database COVID19

    Kategorien

  3. Article ; Online: Dataset of immune responses induced in swine by an inactivated Porcine Circovirus 2b vaccine.

    Guarneri, Flavia / Tresoldi, Enrico Tommaso / Sarli, Giuseppe / Boniotti, Maria Beatrice / Lelli, Davide / Barbieri, Ilaria / Bacci, Barbara / D'Annunzio, Giulia / Amadori, Massimo

    Data in brief

    2021  Volume 35, Page(s) 106906

    Abstract: A whole virus, inactivated, Porcine Circovirus 2b (PCV2b) vaccine was submitted to a quantal assay of potency, as explained in detail in our companion paper [1]. To this purpose, twenty, 45-day old piglets, checked for maternally-derived antibody (MDA), ... ...

    Abstract A whole virus, inactivated, Porcine Circovirus 2b (PCV2b) vaccine was submitted to a quantal assay of potency, as explained in detail in our companion paper [1]. To this purpose, twenty, 45-day old piglets, checked for maternally-derived antibody (MDA), were allocated to four groups of 5 animals each; these were vaccinated with 800/266/88/0 nanograms, respectively, of an inactivated PCV2b strain, consisting of two distinct virion populations. Twenty-six days later, all the pigs were challenged intranasally with the homologous PCV2b strain. In the presence of a clear dose-dependent protection in terms of viremia, no such effect was observed in terms of weight gain after challenge. The 800 and 266-ng payloads were associated with neutralizing antibody titers above the MDA levels in oral fluids. Higher levels of viremia in control and 88-ng groups [1] coincided with a higher Natural Killer activity of tracheobronchial lymph node cells from PCV2-infected pigs. The PCV2 ORF2-specific ELISPOT assay for IFN-g- secreting cells showed very few (2-4) ORF2-specific cells/10
    Language English
    Publishing date 2021-02-22
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 2786545-9
    ISSN 2352-3409 ; 2352-3409
    ISSN (online) 2352-3409
    ISSN 2352-3409
    DOI 10.1016/j.dib.2021.106906
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Clear cell hidradenoma of the hand: A case report in an 83-year old patient.

    Efremov, Kristian / Caterini, Alessandro / Petrungaro, Lidio / De Maio, Fernando / Di Prete, Monia / Ferlosio, Amedeo / Tresoldi, Ilaria / Farsetti, Pasquale

    International journal of surgery case reports

    2020  Volume 75, Page(s) 307–310

    Abstract: Introduction: Clear cell hidradenoma (CCH) is a superficial adnexal tumor of the sweat glands. It generally appears on the trunk or scalp and is uncommon on the upper and lower limbs; it is extremely rare on the hand. CCH tend to be benign, with low ... ...

    Abstract Introduction: Clear cell hidradenoma (CCH) is a superficial adnexal tumor of the sweat glands. It generally appears on the trunk or scalp and is uncommon on the upper and lower limbs; it is extremely rare on the hand. CCH tend to be benign, with low malignancy risk. Treatment is based on complete surgical excision. We report a rare case of a CCH of the palm of the hand in an 83-year old patient.
    Presentation of case: An 83-year old male patient presented with a small mass on the palmar surface of his left hand, which was progressively increasing over 5 years. The tumor was surgically excised after sonography and sent for histologic examination, based on which diagnosis of CCH was made. Three months after surgery, the patient had no recurrence and was symptom free.
    Discussion: CCH is a rare tumor of the distal extremities and to the best of our knowledge, only one case of this tumor on the hand has been reported. Our case represents a rare CCH located at the palm of the hand, which was successfully surgical excised without recurrence. Therefore, CCH needs to be considered in the differential diagnosis when encountering masses on the distal extremities. Hidradenocarcinoma is the malignant variant that arises from the same cells.
    Conclusion: We report the second case of CCH on the palmar surface of the hand. Treatment of choice is surgical excision, followed by histological analysis and close follow-up for recurrence.
    Language English
    Publishing date 2020-09-19
    Publishing country Netherlands
    Document type Case Reports
    ISSN 2210-2612
    ISSN 2210-2612
    DOI 10.1016/j.ijscr.2020.09.111
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Synovial cyst of the acromioclavicular joint with and without rotator cuff tear: A case series of two patients.

    De Maio, Fernando / Di Marcantonio, Arianna / De Luna, Vincenzo / Caterini, Alessandro / Tresoldi, Ilaria / Farsetti, Pasquale

    International journal of surgery case reports

    2020  Volume 75, Page(s) 390–393

    Abstract: Introduction: Acromioclavicular joint cyst (AJC) is a very uncommon condition of the shoulder observed in elderly patients, caused by a degenerative acromioclavicular (AC) joint, frequently associated to a rotator cuff tendon tear. There are two ... ...

    Abstract Introduction: Acromioclavicular joint cyst (AJC) is a very uncommon condition of the shoulder observed in elderly patients, caused by a degenerative acromioclavicular (AC) joint, frequently associated to a rotator cuff tendon tear. There are two possible cause for the cyst formation. We report two different cases of a AC synovial cyst, with and without rotator cuff tear.
    Presentation of cases: We report two cases, in patients aged respectively 80 and 77 years, with a very large AJC. In one case, the cyst was associated to a rotator cuff tear, while in the other case, the rotator cuff did not present any evident lesion. Both cysts were successfully surgical excised and a distal clavicle resection was performed.
    Discussion: AJC is a rare complication observed in degenerative AC joint and in the majority of cases is associated to a rotator cuff tear. The diagnosis may be made by ultrasound and conventional radiographic examination, although MRI of the shoulder is generally preferred as it allows to better identify the condition of the rotator cuff. Generally, local aspiration of the cyst and corticosteroid injection fails with recurrence of the cyst and surgically treatment is indicated, especially in painful cases.
    Conclusion: Painful AJC should be surgically treated by excision of the cyst associated to a lateral clavicle resection; when a symptomatic massive rotator cuff is present, a reverse total shoulder arthroplasty may be considered. However, in elderly patients, who have no discomfort, watchful waiting may be the treatment of choice.
    Language English
    Publishing date 2020-09-16
    Publishing country Netherlands
    Document type Journal Article
    ISSN 2210-2612
    ISSN 2210-2612
    DOI 10.1016/j.ijscr.2020.09.084
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Protective immunity in swine induced by Porcine Circovirus 2b inactivated vaccines with different antigen payload.

    Guarneri, Flavia / Tresoldi, Enrico Tommaso / Sarli, Giuseppe / Boniotti, Maria Beatrice / Lelli, Davide / Barbieri, Ilaria / Bacci, Barbara / D'Annunzio, Giulia / Amadori, Massimo

    Veterinary microbiology

    2020  Volume 252, Page(s) 108887

    Abstract: Porcine Circovirus 2 (PCV2) vaccines are poorly standardized in terms of antigen payload and correlates of protection. Therefore, twenty, 45-day old piglets were divided into four groups of 5 animals each and vaccinated with 800 / 266 / 88 / 0 nanograms, ...

    Abstract Porcine Circovirus 2 (PCV2) vaccines are poorly standardized in terms of antigen payload and correlates of protection. Therefore, twenty, 45-day old piglets were divided into four groups of 5 animals each and vaccinated with 800 / 266 / 88 / 0 nanograms, respectively, of an inactivated PCV2b strain formulated in the same oil adjuvant. Twenty-six days later, all the pigs were challenged intranasally with the homologous PCV2b strain. No clinical signs were observed in the pigs under study. Viremia was observed after challenge in all the control pigs, as well as in 3 pigs of the 266 and 88-ng groups (one and two, respectively). No pigs of the 800-ng group developed viremia. On the basis of post challenge viremia, the PCV2b vaccine under study had a titer of 11 Protective Doses (PD) 50 %, and 1 PD
    MeSH term(s) Animals ; Antibodies, Viral/blood ; Antigens, Viral/immunology ; Circoviridae Infections/prevention & control ; Circoviridae Infections/veterinary ; Circoviridae Infections/virology ; Circovirus/immunology ; Enzyme-Linked Immunosorbent Assay/veterinary ; Interferon-gamma/blood ; Random Allocation ; Recombinant Proteins ; Swine ; Swine Diseases/prevention & control ; Swine Diseases/virology ; Vaccination/veterinary ; Vaccines, Inactivated/immunology ; Viral Load/veterinary ; Viral Vaccines/immunology ; Viremia/prevention & control ; Viremia/veterinary
    Chemical Substances Antibodies, Viral ; Antigens, Viral ; Recombinant Proteins ; Vaccines, Inactivated ; Viral Vaccines ; Interferon-gamma (82115-62-6)
    Language English
    Publishing date 2020-10-13
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 753154-0
    ISSN 1873-2542 ; 0378-1135
    ISSN (online) 1873-2542
    ISSN 0378-1135
    DOI 10.1016/j.vetmic.2020.108887
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Pre-Existing Diabetes and COVID-Associated Hyperglycaemia in Patients with COVID-19 Pneumonia.

    Laurenzi, Andrea / Caretto, Amelia / Molinari, Chiara / Bazzigaluppi, Elena / Brigatti, Cristina / Marzinotto, Ilaria / Mercalli, Alessia / Melzi, Raffaella / Nano, Rita / Tresoldi, Cristina / Landoni, Giovanni / Ciceri, Fabio / Lampasona, Vito / Scavini, Marina / Piemonti, Lorenzo

    Biology

    2021  Volume 10, Issue 8

    Abstract: Aim: The aim of the current study was to compare clinical characteristics, laboratory findings, and major outcomes of patients hospitalized for COVID-19 pneumonia with COVID-associated hyperglycaemia or pre-existing diabetes.: Methods: A cohort of ... ...

    Abstract Aim: The aim of the current study was to compare clinical characteristics, laboratory findings, and major outcomes of patients hospitalized for COVID-19 pneumonia with COVID-associated hyperglycaemia or pre-existing diabetes.
    Methods: A cohort of 176 adult patients with a diagnosis of pre-existing diabetes (
    Results: Patients with COVID-associated hyperglycaemia had lower BMI, significantly less comorbidities, and higher levels of inflammatory markers and indicators of multi-organ injury than those with pre-existing diabetes. No differences between pre-existing diabetes and COVID-associated hyperglycaemia were evident for symptoms at admission, the humoral response against SARS-CoV-2, or autoantibodies to glutamic acid decarboxylase or interferon alpha-4. COVID-associated hyperglycaemia was independently associated with the risk of adverse clinical outcome, which was defined as ICU admission or death (HR 2.11, 95% CI 1.34-3.31;
    Conclusions: Recognizing hyperglycaemia as a specific clinical entity associated with COVID-19 pneumonia is relevant for early and appropriate patient management and close monitoring for the progression of disease severity.
    Language English
    Publishing date 2021-08-05
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2661517-4
    ISSN 2079-7737
    ISSN 2079-7737
    DOI 10.3390/biology10080754
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Treatment of spasticity in children and adolescents with cerebral palsy in Northern Europe: a CP-North registry study.

    Hägglund, Gunnar / Hollung, Sandra Julsen / Ahonen, Matti / Andersen, Guro L / Eggertsdóttir, Guðbjörg / Gaston, Mark S / Jahnsen, Reidun / Jeglinsky-Kankainen, Ira / Nordbye-Nielsen, Kirsten / Tresoldi, Ilaria / Alriksson-Schmidt, Ann I

    BMC neurology

    2021  Volume 21, Issue 1, Page(s) 276

    Abstract: Background: Spasticity is present in more than 80% of the population with cerebral palsy (CP). The aim of this study was to describe and compare the use of three spasticity reducing methods; Botulinum toxin-A therapy (BTX-A), Selective dorsal rhizotomy ( ...

    Abstract Background: Spasticity is present in more than 80% of the population with cerebral palsy (CP). The aim of this study was to describe and compare the use of three spasticity reducing methods; Botulinum toxin-A therapy (BTX-A), Selective dorsal rhizotomy (SDR) and Intrathecal baclofen therapy (ITB) among children and adolescents with CP in six northern European countries.
    Methods: This registry-based study included population-based data in children and adolescents with CP born 2002 to 2017 and recorded in the follow-up programs for CP in Sweden, Norway, Denmark, Iceland and Scotland, and a defined cohort in Finland.
    Results: A total of 8,817 individuals were included. The proportion of individuals treated with SDR and ITB was significantly different between the countries. SDR treatment ranged from 0% ( Finland and Iceland) to 3.4% (Scotland) and ITB treatment from 2.2% (Sweden) to 3.7% (Denmark and Scotland). BTX-A treatment in the lower extremities reported 2017-2018 ranged from 8.6% in Denmark to 20% in Norway (p < 0.01). Mean age for undergoing SDR ranged from 4.5 years in Norway to 7.3 years in Denmark (p < 0.01). Mean age at ITB surgery ranged from 6.3 years in Norway to 10.1 years in Finland (p < 0.01). Mean age for BTX-A treatment ranged from 7.1 years in Denmark to 10.3 years in Iceland (p < 0.01). Treatment with SDR was most common in Gross Motor Function Classification System (GMFCS) level III, ITB in level V, and BTX-A in level I. The most common muscle treated with BTX-A was the calf muscle, with the highest proportion in GMFCS level I. BTX-A treatment of hamstring and hip muscles was most common in GMFCS levels IV-V in all countries.
    Conclusion: There were statistically significant differences between countries regarding the proportion of children and adolescents with CP treated with the three spasticity reducing methods, mean age for treatment and treatment related to GMFCS level. This is likely due to differences in the availability of these treatment methods and/or differences in preferences of treatment methods among professionals and possibly patients across countries.
    MeSH term(s) Adolescent ; Baclofen/administration & dosage ; Botulinum Toxins, Type A/administration & dosage ; Cerebral Palsy/diagnosis ; Cerebral Palsy/epidemiology ; Cerebral Palsy/therapy ; Child ; Child, Preschool ; Cohort Studies ; Europe/epidemiology ; Humans ; Injections, Spinal/methods ; Male ; Muscle Relaxants, Central/administration & dosage ; Muscle Spasticity/diagnosis ; Muscle Spasticity/epidemiology ; Muscle Spasticity/therapy ; Muscle, Skeletal/drug effects ; Muscle, Skeletal/pathology ; Registries ; Rhizotomy/methods
    Chemical Substances Muscle Relaxants, Central ; Botulinum Toxins, Type A (EC 3.4.24.69) ; Baclofen (H789N3FKE8)
    Language English
    Publishing date 2021-07-12
    Publishing country England
    Document type Journal Article
    ISSN 1471-2377
    ISSN (online) 1471-2377
    DOI 10.1186/s12883-021-02289-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Dataset of immune responses induced in swine by an inactivated Porcine Circovirus 2b vaccine

    Guarneri, Flavia / Tresoldi, Enrico Tommaso / Sarli, Giuseppe / Boniotti, Maria Beatrice / Lelli, Davide / Barbieri, Ilaria / Bacci, Barbara / D'Annunzio, Giulia / Amadori, Massimo

    Data in Brief. 2021 Apr., v. 35

    2021  

    Abstract: A whole virus, inactivated, Porcine Circovirus 2b (PCV2b) vaccine was submitted to a quantal assay of potency, as explained in detail in our companion paper [1]. To this purpose, twenty, 45-day old piglets, checked for maternally-derived antibody (MDA), ... ...

    Abstract A whole virus, inactivated, Porcine Circovirus 2b (PCV2b) vaccine was submitted to a quantal assay of potency, as explained in detail in our companion paper [1]. To this purpose, twenty, 45-day old piglets, checked for maternally-derived antibody (MDA), were allocated to four groups of 5 animals each; these were vaccinated with 800/266/88/0 nanograms, respectively, of an inactivated PCV2b strain, consisting of two distinct virion populations. Twenty-six days later, all the pigs were challenged intranasally with the homologous PCV2b strain. In the presence of a clear dose-dependent protection in terms of viremia, no such effect was observed in terms of weight gain after challenge. The 800 and 266-ng payloads were associated with neutralizing antibody titers above the MDA levels in oral fluids. Higher levels of viremia in control and 88-ng groups [1] coincided with a higher Natural Killer activity of tracheobronchial lymph node cells from PCV2-infected pigs. The PCV2 ORF2-specific ELISPOT assay for IFN-g– secreting cells showed very few (2–4) ORF2-specific cells/10⁵ peripheral blood mononuclear cells beyond the basal levels under our experimental conditions (non-significant differences among groups). Also, no significant differences were observed in the degree of lymphoid tissue hyperplasia among the different groups.
    Keywords Porcine circovirus ; data collection ; dose response ; hyperplasia ; lymph nodes ; vaccines ; viremia ; virion ; viruses ; weight gain
    Language English
    Dates of publication 2021-04
    Publishing place Elsevier Inc.
    Document type Article
    ZDB-ID 2786545-9
    ISSN 2352-3409
    ISSN 2352-3409
    DOI 10.1016/j.dib.2021.106906
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  10. Article: Protective immunity in swine induced by Porcine Circovirus 2b inactivated vaccines with different antigen payload

    Guarneri, Flavia / Tresoldi, Enrico Tommaso / Sarli, Giuseppe / Boniotti, Maria Beatrice / Lelli, Davide / Barbieri, Ilaria / Bacci, Barbara / D’Annunzio, Giulia / Amadori, Massimo

    Veterinary microbiology. 2021 Jan., v. 252

    2021  

    Abstract: Porcine Circovirus 2 (PCV2) vaccines are poorly standardized in terms of antigen payload and correlates of protection. Therefore, twenty, 45-day old piglets were divided into four groups of 5 animals each and vaccinated with 800 / 266 / 88 / 0 nanograms, ...

    Abstract Porcine Circovirus 2 (PCV2) vaccines are poorly standardized in terms of antigen payload and correlates of protection. Therefore, twenty, 45-day old piglets were divided into four groups of 5 animals each and vaccinated with 800 / 266 / 88 / 0 nanograms, respectively, of an inactivated PCV2b strain formulated in the same oil adjuvant. Twenty-six days later, all the pigs were challenged intranasally with the homologous PCV2b strain. No clinical signs were observed in the pigs under study. Viremia was observed after challenge in all the control pigs, as well as in 3 pigs of the 266 and 88-ng groups (one and two, respectively). No pigs of the 800-ng group developed viremia. On the basis of post challenge viremia, the PCV2b vaccine under study had a titer of 11 Protective Doses (PD) 50 %, and 1 PD₅₀ amounted to 74 ng of PCV2b Ag. Neutralizing and ELISA Ab titers showed no obvious correlation with protection in the single animals, even though the 800-ng group developed a significantly higher mean Ab response. All the pigs with a PCV2-specific, IFN-gamma response at 3 weeks after vaccination in whole blood samples were protected against viremia. In lymphoid tissues (mainly tonsils and ileum) the presence of sparse reactive histiocytes and multinucleated giant cells was the only PCV2-associated feature and, by immunohistochemistry, only 3 out of 20 subjects showed a low viral load.
    Keywords Porcine circovirus ; Porcine circovirus-2 ; adjuvants ; antigens ; blood ; histiocytes ; ileum ; immunity ; immunohistochemistry ; microbiology ; oils ; vaccination ; viral load ; viremia
    Language English
    Dates of publication 2021-01
    Publishing place Elsevier B.V.
    Document type Article
    Note NAL-AP-2-clean
    ZDB-ID 753154-0
    ISSN 1873-2542 ; 0378-1135
    ISSN (online) 1873-2542
    ISSN 0378-1135
    DOI 10.1016/j.vetmic.2020.108887
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

To top